Five months' follow-up of patients with and without iodine-positive lymph node metastases of thyroid carcinoma as disclosed by 131I-SPECT/CT at the first radioablation

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 37, Issue 4, 2010, Pages 699-705

  Schmidt, Daniela ^a   Linke, Rainer ^a   Uder, Michael ^a   Kuwert, Torsten ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Hybrid imaging; Radioiodine; SPECT CT; Thyroid carcinoma

Indexed keywords

IODINE 131; THYROTROPIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CERVICAL LYMPH NODE; CLINICAL EVALUATION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PROGNOSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; THYROID CARCINOMA; THYROID SCINTISCANNING; THYROIDECTOMY; TREATMENT RESPONSE; TUMOR ABLATION; WHOLE BODY SCINTISCANNING;

ADENOCARCINOMA, FOLLICULAR; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, PAPILLARY; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; IODINE RADIOISOTOPES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM, RESIDUAL; PATIENT CARE PLANNING; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; REOPERATION; THYROID NEOPLASMS; THYROIDECTOMY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, SPIRAL COMPUTED; WHOLE BODY IMAGING; YOUNG ADULT;

EID: 77952094370     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-009-1299-2     Document Type: Article

References (26)

1. SM Seidlin LD Marinelli E Oshry 1946 Radioactive iodine therapy: effect on functioning metastases of adenocarcinoma of the thyroid JAMA 132 838 847 1:STN:280:DyaH2s%2Fjs1eqtA%3D%3D
2. MR Carlisle C Lu IR McDougall 2003 The interpretation of 131I scans in the evaluation of thyroid cancer, with an emphasis on false positive findings Nucl Med Commun 24 715 735 10.1097/00006231-200306000-00015 1:STN:280: DC%2BD3s3ovVCjtQ%3D%3D 12766609
3. Y Seo C Mari BH Hasegawa 2008 Technological development and advances in single-photon emission computed tomography/computed tomography Semin Nucl Med 38 177 198 10.1053/j.semnuclmed.2008.01.001 18396178 (Pubitemid 351466914)
4. A Bockisch LS Freudenberg D Schmidt T Kuwert 2009 Hybrid imaging by SPECT/CT and PET/CT: proven outcomes in cancer imaging Semin Nucl Med 39 276 289 10.1053/j.semnuclmed.2009.03.003 19497404
5. K Tharp O Israel J Hausmann L Bettman WH Martin M Daitzchman, et al. 2004 Impact of 131I-SPECT/CT images obtained with an integrated system in the follow-up of patients with thyroid carcinoma Eur J Nucl Med Mol Imaging 31 1435 1442 10.1007/s00259-004-1565-2 1:STN:280:DC%2BD2cvnvFeltQ%3D%3D 15221294 (Pubitemid 39361941)
6. J Ruf L Lehmkuhl H Bertram D Sandrock H Amthauer B Humplik, et al. 2004 Impact of SPECT and integrated low-dose CT after radioiodine therapy on the management of patients with thyroid carcinoma Nucl Med Commun 25 1177 1182 10.1097/00006231-200412000-00004 15640775 (Pubitemid 39614278)
7. L Chen Q Luo Y Shen Y Yu Z Yuan H Lu, et al. 2008 Incremental value of 131I SPECT/CT in the management of patients with differentiated thyroid carcinoma J Nucl Med 49 1952 1957 10.2967/jnumed.108.052399 18997044
8. KK Wong N Zarzhevsky JM Cahill KA Frey AM Avram 2008 Incremental value of diagnostic 131I SPECT/CT fusion imaging in the evaluation of differentiated thyroid carcinoma AJR Am J Roentgenol 191 1785 1794 10.2214/AJR.08.1218 19020251
9. S Kohlfuerst I Igerc M Lobnig HJ Gallowitsch I Gomez-Segovia S Matschnig, et al. 2009 Posttherapeutic (131)I SPECT-CT offers high diagnostic accuracy when the findings on conventional planar imaging are inconclusive and allows a tailored patient treatment regimen Eur J Nucl Med Mol Imaging 36 886 893 10.1007/s00259-008-1044-2 1:STN:280:DC%2BD1MzjtVaqsA%3D%3D 19169681
10. A Spanu ME Solinas F Chessa D Sanna S Nuvoli G Madeddu 2009 131I SPECT/CT in the follow-up of differentiated thyroid carcinoma: incremental value versus planar imaging J Nucl Med 50 184 190 10.2967/jnumed.108.056572 19164225
11. D Schmidt A Szikszai R Linke W Bautz T Kuwert 2009 Impact of 131I SPECT/spiral CT on nodal staging of differentiated thyroid carcinoma at the first radioablation J Nucl Med 50 18 23 10.2967/jnumed.108.052746 19091884
12. F Pacini M Schlumberger H Dralle R Elisei JWA Smit W Wiersinga, et al. 2006 European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium Eur J Endocrinol 154 787 803 10.1530/eje.1.02158 1:CAS:528:DC%2BD28XmsVKrurY%3D 16728537 (Pubitemid 43997716)
13. Greene FL, Page DL, Fleming ID, Fritz A, Balch CM. AJCC cancer staging handbook. New York: Springer; 2002.
14. AM Sawka K Thephamongkhol M Brouwers L Thabane G Browman HC Gerstein 2004 Clinical review 170: a systematic review and metaanalysis of the effectiveness of radioactive iodine remnant ablation for well-differentiated thyroid cancer J Clin Endocrinol Metab 89 3668 3676 10.1210/jc.2003-031167 1:CAS:528: DC%2BD2cXmslKmsbc%3D 15292285 (Pubitemid 39089119)
15. AM Sawka JD Brierley RW Tsang L Thabane L Rotstein A Gafni, et al. 2008 An updated systematic review and commentary examining the effectiveness of radioactive iodine remnant ablation in well-differentiated thyroid cancer Endocrinol Metab Clin North Am 37 457 480 10.1016/j.ecl.2008.02.007 18502337 (Pubitemid 351711675)
16. D Handkiewicz-Junak J Wloch J Roskosz J Krajewska A Kropinska L Pomorski, et al. 2007 Total thyroidectomy and adjuvant radioiodine treatment independently decrease locoregional recurrence risk in childhood and adolescent differentiated thyroid cancer J Nucl Med 48 879 888 10.2967/jnumed.106.035535 1:CAS:528:DC%2BD2sXhtVert7bJ 17536106 (Pubitemid 46909915)
17. EL Mazzaferri RT Kloos 2001 Clinical review 128: current approaches to primary therapy for papillary and follicular thyroid cancer J Clin Endocrinol Metab 86 1447 1463 10.1210/jc.86.4.1447 1:CAS:528:DC%2BD3MXivVCltLw%3D 11297567 (Pubitemid 32374886)
18. ID Hay IR McDougall JC Sisson 2009 A Proposition for the use of radioiodine in WDTC management J Nucl Med 50 329 330 10.2967/jnumed.108.057349
19. FA Verburg M Dietlein M Lassmann M Luster C Reiners 2009 Why radioiodine remnant ablation is right for most patients with differentiated thyroid carcinoma Eur J Nucl Med Mol Imaging 36 343 346 10.1007/s00259-008-0997-5 19050874
20. S Bonnet D Hartl S Leboulleux E Baudin JD Lumbroso A Al Ghuzlan, et al. 2009 Prophylactic lymph node dissection for papillary thyroid cancer less than 2 cm: implications for radioiodine treatment J Clin Endocrinol Metab 94 1162 1167 10.1210/jc.2008-1931 1:CAS:528:DC%2BD1MXksFait7k%3D 19116234
21. N Ali C Sebastian RR Foley I Murray AL Canizales PJ Jenkins, et al. 2006 The management of differentiated thyroid cancer using 123I for imaging to assess the need for 131I therapy Nucl Med Commun 27 165 169 10.1097/01.mnm.0000194397. 20067.b6 16404230 (Pubitemid 44391826)
22. E Gemsenjäger A Perren B Seifert G Schüler I Schweizer PU Heitz 2003 Lymph node surgery in papillary thyroid carcinoma J Am Coll Surg 197 182 190 10.1016/S1072-7515(03)00421-6 12892795 (Pubitemid 36927380)
23. M Shindo JC Wu EE Park F Tanzella 2006 The importance of central compartment elective lymph node excision in the staging and treatment of papillary thyroid cancer Arch Otolaryngol Head Neck Surg 132 650 654 10.1001/archotol.132.6.650 16785411 (Pubitemid 43927043)
24. A Machens HJ Holzhausen H Dralle 2004 Skip metastases in thyroid cancer leaping the central lymph node compartment Arch Surg 139 43 45 10.1001/archsurg.139.1.43 14718274 (Pubitemid 38049617)
25. C Durante N Haddy E Baudin S Leboulleux D Hartl JP Travagli, et al. 2006 Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy J Clin Endocrinol Metab 91 2892 2899 10.1210/jc.2005-2838 1:CAS:528: DC%2BD28XosFGhs70%3D 16684830 (Pubitemid 44271732)
26. P Zanotti-Fregonara G Grassetto E Hindié D Rubello 2009 A low thyroglobulin level cannot be used to avoid adjuvant 131I therapy after thyroidectomy for thyroid carcinoma Eur J Nucl Med Mol Imaging 36 169 171 10.1007/s00259-008-0963-2 18850097